SCHLACKMAN SCOTT 4
4 · MEDIFAST INC · Filed Mar 14, 2023
Insider Transaction Report
Form 4
MEDIFAST INCMED
SCHLACKMAN SCOTT
Director
Transactions
- Exercise/Conversion
Common Stock
2023-03-10$27.68/sh+2,200$60,896→ 9,480.092 total - Sale
Common Stock
2023-03-10$108.68/sh−2,200$239,096→ 7,280.092 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-03-10−2,200→ 1,300 totalExercise: $27.68Exp: 2026-02-04→ Common Stock (2,200 underlying)
Footnotes (1)
- [F1]The reporting person received 5,000 stock options on February 4, 2016 pursuant to the Medifast, Inc. Amended and Restated 2012 Share Incentive Plan. These options vested in three equal annual installments beginning on February 4, 2017.